Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors

Weiping Li(Chinese Academy of Sciences), Mamta Gupta(ICAR-Indian Institute of Maize Research)
Journal of Hematology & Oncology
July 9, 2019
Cited by 108


Related Papers